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Abstract.  Chinese hamster ovary (CHO) suspension 
culture cells adhere readily to substrata coated with 
extracellular matrix proteins such as fibronectin, 
vitronectin, or laminin. In the case of fibronectin, it is 
known that adhesion is mediated by an integrin-type, 
cell surface fibronectin receptor (FnR).  We demon- 
strate here that treatment of CHO cells with sub- 
micromolar concentrations of phorbol ester produces a 
remarkable increase in the ability of these cells to ad- 
here to fibronectin. Both the rate of adhesion and the 
efficiency of adhesion are enhanced about four- to 
fivefold. Further, phorbol ester treatment renders the 
fibronectin-mediated adhesion process less sensitive to 
inhibitors,  including GRGDSP peptide and PB1,  a 
monoclonal anti-FnR antibody. By contrast, 
nonspecific adhesion processes,  for example cell at- 
tachment to substrata coated with polylysine or con- 
canavalin A, are not affected by phorbol ester treat- 
ment. Thus integrin-mediated adhesion is modulated 
by phorbol esters, but nonspecific adhesion is not. 
Neither the number of cell surface FnRs nor the 
receptor affinity, as measured by ~25I-fibronectin and 
'25I-anti-FnR  antibody binding, is altered by phorbol 
ester treatment. Thus, the effect of phorbol ester on 
cell adhesion seems to occur at a  step subsequent to 
initial ligand-receptor binding events. Since phorbol 
ester is a potent activator of protein kinase C, we ex- 
amined phosphorylation patterns in control and 
phorbol-treated cells. In immunoprecipitates of lysates 
from suspension culture cells, there was no evidence 
of phorbol ester-stimulated phosphorylation of FnR or 
of talin, a protein thought to interact with FnR.  These 
results suggest that phorbol ester effects on fibronectin- 
dependent adhesion are not due to phosphorylation of 
the FnR itself but rather may be due to postreceptor 
events, possibly the phosphorylation of cytoskeletal 
proteins involved in integrin-mediated adhesion. 
T 
HE adhesion of cells to the extracellular matrix is a 
complex process which involves metabolic and cyto- 
skeletal activities as well as cell surface receptors for 
matrix macromolecules (11, 29).  Within the last few years 
two major families of matrix adhesion receptors have been 
described. The integrin or "cytoadhesin" family (3, 27, 49) 
is comprised of  a number of heterodimeric receptors of ,~ 140 
kD in molecular mass. These molecules are involved in a 
wide variety of cell-matrix and cell-cell adhesive processes 
in neuronal (18), immune (56, 57), connective tissue (7, 14), 
and hematopoietic (40, 41) cellular systems. The integrin su- 
perfamily includes mammalian receptors for fibronectin (7, 
43), vitronectin (44), collagen, and laminin (58, 59). The in- 
teractions of many, but not all, integrins with their specific 
ligands can be  inhibited by short peptides containing the 
RGD adhesive sequence (48,  56,  60).  High affinity mam- 
malian cell  receptors  for laminin and elastin  seem  to  be 
members of  another family  of matrix adhesion receptors (22, 
36, 45). These molecules are in the 65-70-kD range and, in 
the case of laminin receptor, bind to a YIGSR sequence in 
the ligand molecule; this type of laminin receptor is found 
largely in epithelial cells rather than fibroblastic cells (19). 
Integrin-type laminin receptors have also been detected in 
avian cells (24) and in mammalian cells (33, 58). In addition 
to the integrin and laminin/elastin receptor families, a num- 
ber of other apparently distinct matrix adhesion receptors 
have been described (31, 55).  Furthermore, it is also clear 
that membrane proteoglycans can play an important role in 
cell adhesion to extracellular matrix (17). 
It is becoming increasingly certain that receptor-mediated 
cell adhesion, like many specific cellular processes, is regu- 
lated by the action of protein kinases (26, 34).  Thus, onco- 
genic viruses which express tyrosine kinases have long been 
known to have profound effects  on cell adhesiveness and 
morphology (13). Recently, it has been shown that the cyto- 
plasmic domains of some integrins are a target for viral tyro- 
sine kinases (23) and that this may lead to altered interactions 
between integrins and the cytoskeleton. Serine/threonine ki- 
nases also play an important role in the regulation of cell 
adhesion. Phenomenological effects of cAMP analogues on 
cell  adhesiveness and morphology have  been  known  for 
many years (13). Further, we recently have demonstrated a 
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regulation of fibronectin-mediated adhesion (15, 16). Protein 
kinase  C,  an  enzyme stimulated  by phorbol  ester  tumor 
promoters (39), is also likely to be an important modulator 
of cell adhesion. 
There is a diverse literature on the effects of phorbol esters 
(these effects presumably mediated by protein kinase C) on 
cell adhesion and morphology. Thus,  in some cases (51), 
phorbol ester treatment has caused disruption of the cyto- 
skeleton and cell rounding when cells spread on the surface. 
By contrast, there are many reports indicating that phorbols 
cause an increase in the adhesiveness of monocytic and gran- 
ulocytic cells (5, 47); this process takes many hours and may 
involve induced expression of new proteins. With regard to 
integrin-mediated adhesion, a recent, intriguing report (12) 
indicates that, in lymphoid ceils treated with phorbol ester, 
capping of cell surface integrin molecules will lead to cocap- 
ping of talin, an internal cytoskeletal component. This sug- 
gests a phorbol ester-regulated link between integrins and 
the cytoskeleton. The relationship of this cocapping process 
to phorbol ester effects on cell adhesion was not examined. 
Rothlein and  Springer  (46)  have observed that  leukocyte 
aggregation mediated by LFA-1, a  member of the integrin 
family, is  enhanced by phorbol ester treatment.  Enhance- 
ment of fibronectin-mediated cell spreading and induction of 
morphological changes by phorbol ester has also been ob- 
served in an erythroleukemic cell line (28). 
In this report we have examined effects of phorbol ester 
(PMA)  treatment on the adhesion behavior of suspension 
cultured  Chinese  hamster  ovary  (CHO) ~ cells.  This  is  a 
useful system for quantitatively studying early events in cell 
adhesion in a cell population which is not perturbed by the 
methods one usually uses to dislodge monolayer cells. A pre- 
liminary report by Brown (6) indicated that PMA and other 
agents which stimulate protein kinase C, but not inactive ana- 
logues, had a rapid effect on CHO cell adhesion. We show 
here that PMA treatment produces a rapid and profound en- 
hancement of integrin-mediated  cell  adhesion,  using  the 
fibronectin receptor (FnR) as a model. We further demon- 
strate that the actions of PMA on adhesion are not due to 
changes in the cell surface expression or affinity of the FnR. 
Finally, we show that changes in the phosphorylation state 
of FnR do not occur subsequent to phorbol ester treatment; 
indeed, the receptor is a very poor substrate for the kinases 
present in CHO cells. This suggests that phorbol ester regu- 
lation of integrin-mediated cell adhesion is a postreceptor 
event, probably due to the phosphorylation of cytoskeletal 
proteins which are involved in this type of adhesion process. 
Materials and Methods 
Reagents 
Cell culture media (alpha MEM), fetal calf serum, and antibiotics (cata- 
logue no. 600-5240AG)  were supplied by Gibco Laboratories (Grand Is- 
land, NY). PMA, metrizamide, and leupeptin were from Sigma Chemical 
Co. (St. Louis, MO). Adhesion-inhibiting peptide (GRGDSP) and control 
peptide (GLGDSP)  were prepared by the  Protein Core Facility of the 
University of North Carolina at Chapel Hill (Chapel Hill, NC). Isotopes 
including 35S-translabel  (1,000 Ci/mM), [32P]orthophosphate  (285 Ci/mg), 
1. Abbreviations  used in this paper:  CHO, Chinese hamster ovary; FnR, 
fibronectin receptor. 
[32P]gamma ATP (7,000  Ci/mM), and 125I-Bolton-Hunter  reagent (2,000 
Ci/mM) were from ICN Laboratories, Inc. (Plainview,  NY). Bovine albu- 
min fraction V (BSA) was obtained from Miles Laboratories, Inc.  (Naper- 
ville, [L), protein A-Sepharose 4B was from Pharmacia Fine Chemicals 
(Piscataway, NJ), Affigel from Bio-Rad Laboratories (Richmond, CA), and 
Cronex-7  autoradiography film was from DuPont Co. (Wilmington, DE). 
Bovine plasma fibronectin was prepared as previously described (52, 53). 
Vitronectin was prepared from human plasma (50) except that the fast per- 
formance  liquid  chromatography (FPLC)  ion-exchange chromatography 
was performed on a MonoQ-5 (Pharmacia Fine Chemicals) column, with 
a 20 mM Tris (pH 7.6) starting buffer in the absence of urea. Laminin was 
purchased from Collaborative Research, Inc.  (Waltham, MA). Anti-FnR 
antibodies  including  PB1  monoclonal and  goat  antireceptor polyclonal 
(anti-gpl40) antibodies have been previously described (7-10).  Antitalin 
polyclonal antibody was obtained from Dr. Keith Burridge, Department of 
Cell Biology, University of North Carolina at Chapel Hill. All other chemi- 
cals were of reagent grade. 
Cells and Adhesion Assays 
Wild-type CHO  suspension culture cells were grown as previously de- 
scribed (20,  21). For adhesion assays, exponentially growing cells (105- 
106/ml) were labeled over night with 35S-translabel  (2-5 #Ci/ml), washed 
in alpha MEM plus 1% BSA, and then used in the assay. Substrata coated 
with various concentrations of fibronectin, laminin, or vitronectin were pre- 
pared in 24-well Costar (Cambridge, MA) polystyrene tissue culture plates 
as previously described (7); bovine albumin (3 %) was used to block residual 
protein adsorbtion sites on the plastic. In various experiments, different 
batches of fibronectin with differing potencies in promoting adhesion were 
used; thus, internal controls are provided in all experiments. Radiolabeled 
cells were suspended in alpha MEM plus  1% BSA and allowed to attach 
to the substrata (0.5 ml/well) during various periods of incubation in a 37°C 
incubator.  Thereafter, unattached cells were removed by washing with alpha 
MEM plus 1% BSA at 37°C and the residual attached cells lysed with 2% 
SDS, transferred to scintillation fluid, and counted in a scintillation counter. 
Results of adhesion assays are expressed either as a percent of the total num- 
ber of cells or as a percent of positive control (adhesion to substrata in the 
absence of inhibitors). The number of cells in suspension was measured 
with a particle counter (ElectroZone Celloscope). In some cases cells were 
treated, in suspension, with various doses of PMA before the adhesion as- 
say. In most cases a 10-min preincubation period with 1 #M PMA was used 
and the unbound drug was washed away from the cells before the adhesion 
process began. The PMA was added as a DMSO solution (fnal concentra- 
tion in cell suspension was 0.1%; controls contained equivalent amounts of 
DMSO). The data in adhesion assays represent triplicate independent mea- 
surements from at least three separate experiments. 
Binding Experiments 
Bovine plasma fibronectin was radioiodinated with BoRon-Hunter reagent 
according to the manufacturer's recommendations, to a specific activity of 
1.0-1.5 tzCi/mg protein. Binding of 125I-fibronectin to washed, suspension- 
culture CHO cells was performed essentially according to the method of 
Akiyama and Yamada (1, 2), with the following modifications: (a) specific 
and nonspecific binding were distinguished by use of GRGDSP (2.5 mM) 
to inhibit specific binding (GLGDSP was used in a concentration, 2.5 mM 
as an inactive peptide); (b) cells were separated from the ligand by sedimen- 
tation (2,500 g) through a layer of 10% metrizamide in alpha MEM plus 
1% BSA. Binding was done at 20°C since previous results have indicated 
little difference in binding at 4°C vs. 20°C (2) and fewer problems with 
fibronectin aggregation are encountered at 20°C. The level of total t251-fi- 
bronectin binding was ,'°20,000  cpm/sample at 135 p.g/ml fibronectin (the 
highest concentration used),  while the level of nonspecific binding was 
13,000 cpm/sample. PB1, a specific anti-FnR monoclonal antibody (7) was 
labeled with t25I-Bolton-Hunter reagent to 100-150 #Cf/mg. Binding of la- 
beled PBI to washed CHO cells was performed at 4°C; a  100x  excess of 
unlabeled PB1 was used to distinguish specific from nonspecific binding, 
and the excess unbound I25I-antibody was removed by pelleting the cells 
and washing several times in cold buffer. The Enzfitter (Robin J. Leatherbar- 
row Ltd., London, UK) program was used to convert binding data to Scatch- 
ard plots and to calculate values for binding affinities and number of sites 
for fibronectin and for PBI. 
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Figure 1. (A) Kinetics of adhesion to fibronectin-coated substrata. 
Tissue culture plates were coated with 0.5/~g/ml of fibronectin and 
then blocked with bovine albumin. CHO cells were prelabeled with 
3sS  as described in  Materials and  Methods,  treated with  PMA 
(1 izM) or maintained as controls, suspended at 0.5  ×  10S/ml in al- 
pha MEM plus 1% BSA, and allowed to adhere at 37°C for different 
time intervals. The attached cells were recovered and analyzed for 
radioactivity as described. This was then converted into the per- 
centage of adherent cells. (o) PMA treated; (o) control; ordinate, 
% cells adhered; abcissa, time. (B)  PMA dose-response curve. 
CHO  cells were labeled with ~5S as above and pretreated with 
different concentrations of PMA as above. Cells were then sus- 
pended in alpha MEM plus 1% BSA at l@/ml and allowed to at- 
tach to tissue culture plates (precoated with 1/zg/ml fibronectin and 
blocked with BSA as above) for 30 or 60 min at 370C. The adherent 
cells were recovered and counted for radioactivity as above. (e) 60 
min; (A) 30 min; ordinate, % cells adhered; abcissa, concentration 
of PMA in nanomoles. (C) Efficiency for CHO cell adhesion to fi- 
bronectin. Tissue culture plates were coated with different concen- 
trations of fibronectin for 2 h at 37°C in PBS, then blocked with BSA 
as in Materials and Methods. Control or PMA-treated (1/~M) cells, 
prelabeled with 3sS, were suspended to l0  s cells/ml and allowed to 
adhere for 45 rain. The adherent cells were recovered and analyzed 
for radioactivity. (e) PMA treated; (o) control; abeissa, concen- 
tration of fibronectin (/~g/ml); ordinate,  % cells adhered. 
Phosphorylation Experiments 
Investigation  of the Time Course  of PMA-induced Phosphorylation  of 
FhR and of Talin. CHO cells preincubated for 2 h with 32pi in alpha MEM 
plus serum, were exposed to 1 #M or 100 nM of  PMA. Cells were incubated 
with PMA for various periods at 37°C and then lysed at 4°C for 10 rain 
with a pH 7.2 lysis buffer containing nonionic detergent and inhibitors of 
proteolysis and of phosphatases (20 mM Tris, 2 mM sodium vanadate, 40 
mM sodium molybdate, 80 mM sodium pyrophosphate, 40 mM potassium 
phosphate monobasic, 2% Triton X-100, 4 mM EGTA, 2 mM PMSE 0.2 
mM trifluoroperazine, 0.2 mM leupeptin). FnR was immunoprecipitated 
using PBI monoclonal antibody coupled to Aftigel (Bio-Rad Laboratories) 
(50/zl of gei/ml; PBI-Attigel produced according to Bio-Rad Laboratories 
recommendations using 2 nag of PB1 per 1 ml of Affigel); talin was precipi- 
tated with rabbit antitalin and protein A-Sepharose 4B.  In some instances 
the lysates were precleared with Affigel blocked with ethanolamine. The 
pellets were dissolved in electrophoresis sample buffer and analyzed by 
SDS-PAGE (10% acrylamide) according to Laemmli (35). Gels were trans- 
blotted to  nitrocellulose; 32P-labeling  was  detected by autoradiography, 
while the location of FnR or talin was visualized by immunoblotting with 
specific antibodies, as described previously (9) or by silver staining. 
Additional  Whole Cell or Broken Cell Phosphorylation  Experiments. 
To confirm low molar incorporation of 32Pi into FnR, some incubations 
were done in phosphate-free medium containing glucose, subsequent to an 
initial period of depletion of cellular ATP pools by incubation in glucose- 
free medium. Thus, cells (4  x  108) were washed with buffer A (135 mM 
NaCI, 3 mM KCI, 20 mM NaHCO3,  10 mg/ml BSA, 1 mM CaCI2, 2 mM 
MgCI2,  1% antibiotics, pH 7.5),  resuspended in 50 ml of the same buffer, 
and incubated for 4  h at 37°C.  Thereafter, cells were sedimented, resus- 
pended in 4 ml of buffer A plus 1 mM adenosine, 12 mM glucose, 2 mCi 
32pi, and incubated for 1.5 h at 37°C followed by washing with PBS. CHO 
cells charged with 32pi were exposed to 1 #M PMA for 10 rain at 37°C and 
lysed with 5 ml of 100 mM octylglucoside plus phosphatase inhibitors (see 
above) at 4°C. The lysate supernatant (5,000 g) was precleared with 150 #1 
of ethanolamine-blocked Afligel for 2 h at 4°C followed by incubation with 
150/zl of PB1-Affigel for the same time. Beads of specific and nonspecific 
Affigel were exhaustively washed with lysis buffer and bound proteins were 
solubilized in SDS-containing sample buffer and analyzed by PAGE (35). 
In vitro phosphorylatiorl of CHO membrane proteins was performed as 
follows. Cells (109) were washed in alpha MEM and were swollen in 5 ml 
of 20 mM Hepes, 10 mM MgCI2,  1% BSA, 2  mM PMSF (buffer B) for 
10 rain at 4°C. Cells were broken in a  10-ml glass/glass homogenizer (15 
strokes). The homogenate was centrifuged at 500 g  for 5 min to remove 
nuclei and the supernatant was collected and overlaid on 50%  sucrose in 
buffer B and centrifuged at 20000 rpm in a SW 27 rotor (Beckman Instru- 
ments, Inc., Fullerton, CA) for 20 rain. The pellet was resuspended in buffer 
B, homogenized  as above, and resedimented through 50% sucrose as above. 
The final  pellet, which contained membrane fragments visible by phase- 
contrast microscopy, was resuspended in 10 ml of buffer A plus 4 mM NaF, 
10 #M ATE  1 mCi gamma [32p]ATP. An aliquot (5 ml) was exposed to 
100/~M PMA for l0 min at 37°C while another aliquot was incubated as 
a control; thereafter, samples were lysed with octylglucoside plus phospha- 
tase inhibitors as above.  FnR was precipitated with PB1-Afligel  as above. 
Results 
Effect of  PMA on Kinetics and E~ciency of  Adhesion 
to Fibronectin Substrata 
The effect of brief treatment with PMA on the rate of adhe- 
sion of CHO cells to fibronectin-coated substrata is shown 
in Fig. 1 A. A concentration of 1 #M PMA causes an approx- 
imately fivefold increase in the rate of adhesion. The dose- 
response  relationship for this effect is shown  in  Fig.  1 B, 
which indicates the percent of adherent cells vs. the concen- 
tration of PMA after allowing cells either 30 or 60 min to 
adhere.  Doses as low as 3  nM  have noticeable effects on 
stimulating cell adhesion,  while the  EDs0  is  '~10-20 nM, 
and saturation of the effect occurs at 100 nM; doses of up to 
1 /~M continue to show a  pronounced enhancement of cell 
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Figure 2. (A) Inhibition  of adhe- 
sion by RGD peptides.  CHO cells 
were  prelabeled  with  35S, and 
pretreated with 1/~M PMA for 10 
rain at 37°C. The cells in suspen- 
sion (2  x  10~/ml) were then al- 
lowed to adhere in the presence of 
different concentrations  of GRG- 
DSP-to tissue culture plates coated 
with 1/tg/ml of fibronectin for 1 h 
at 37°C. The adherent ceils were 
recovered and analyzed for radio- 
activity. Inactive peptide GLGDSP at concentrations of 2 mM had no effect on adhesion (not shown). (B) Inhibition of adhesion by anti-FnR 
monoclonal  antibody. CHO cells were prelabeled  with 35S, pretreated  with PMA (1 /~M), and allowed to adhere  at  1.5  x  105 cells/ml to 
plates coated with fibronectin (1/~g/ml) for 1 h at 37°C. The medium contained various amounts of PB1 antireceptor monoclonal antibody. 
Antibody presence  in the media of nonimmune  mouse IgG in concentrations  of 20/zg/ml had no effect on cell adhesion (not shown). (e) 
PMA treated;  (o) control. 
adhesion.  The  characteristics  of the  PMA  dose-response 
curve shown here are similar to those for protein kinase C 
activation by PMA (4, 39). The data of Fig. 1 C demonstrate 
that  PMA treatment  causes  a  marked enhancement  of the 
ability of CHO cells to attach to substrata coated with low 
concentrations of fibronectin; that is the overall efficiency of 
fibronectin use is enhanced.  Thus, there is approximately a 
half-log left shift in the dose-response curve for CHO cell 
adhesion to fibronectin. 
PMA Effects on the Potency of lnhibitors of  Adhesion 
to Fibronectin 
We next investigated the influence of PMA on inhibition of 
cell adhesion to fibronectin produced by either anti-FnR an- 
tibody or by RGD peptide (42).  As seen in Fig.  2 A, brief 
pretreatment of cells with PMA causes a marked right shift 
in the dose-response curve for inhibition by GRGDSE The 
ICs0 shifts from 0.6 mM for untreated cells to 3.0 mM for 
PMA-treated cells. In other words, GRGDSP becomes a less 
potent inhibitor of adhesion with PMA-treated cells. In like 
manner, PMA treatment causes a pronounced right shift in 
the  inhibition  curve  for  PB1  antibody  (Fig.  2  B).  These 
results coupled with those of Fig.  1 C might be interpreted 
as an increase in the number or affinity of FnR sites on the 
cell surface due to PMA treatment.  However, this is appar- 
ently not the case as indicated below. 
PMA Treatment Does Not Directly Affect FnR 
We measured the binding of '2sI-PB1 to control cells and to 
cells  treated  with  PMA  under  the  same circumstances  as 
those which produce enhanced cell adhesion. PB1 is a mono- 
clonal antibody which reacts only with mature,  functional 
FnR and not with other integrins (7-10; also Szeckan, M., 
and R. L. Juliano, unpublished observations); although we 
do not know if there is only one PB1 epitope per receptor, 
nonetheless,  the binding of PBI should be proportionate to 
the number of cell  surface receptors.  As seen  in Fig.  3 A 
there is no difference in the specific or nonspecific binding 
of ~2sI-PB1 between  control  and  PMA-treated  CHO  cells; 
this  finding  was  confirmed  in  several  independent  experi- 
ments.  Similarly, we measured the binding of ~25I-fibronec- 
tin to control and PMA-treated CHO cells.  As seen in Fig. 
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Figure 3. (A) Binding of 125I-PB1 
monoclonal  antibody  to  CHO 
cells.  CHO  cells  were  treated 
with  1/tM  PMA for  10 rain at 
37°C, or maintained  as controls. 
Cells  (0.9  x  106/ml) were then 
exposed to ]25I-labeled PBI anti- 
FnR monoclonal antibody in 1 ml 
alpha  MEM  plus  1%  BSA  for 
1 h at 4°C. Cells plus bound anti- 
body  were  separated  from  un- 
bound antibody by centrifugation 
and repeated  washing  in cold alpha 
MEM plus 1% BSA. Cells treated 
with a  100× excess of unlabeled  PBI served  as a control for specific binding.  (B) Binding of ~25I-fibronectin  to CHO cells.  CHO cells 
were treated  with  l  /zM PMA for 10 min at 37°C or maintained  as controls. Cells  (1.2  x  107/ml) were then incubated  with various 
amounts of t25I-fibronectin (1.5 #Ci/mg) in the presence of 2.5 mM active (GRGDSP) or inactive  (GLGDSP) peptide for 1 h at 20°C. 
Cells and bound fibronectin  were separated  from unbound fibronectin  by centrifugation  of 100/zl of binding mixture (2,500 g for 5 min) 
in polypropylene tubes (0.4 ml Sardstedt) through 250 #l of a 10% metrizamide layer; the samples were frozen and the tube tips containing 
the pellets  were  removed  with  cutting pliers  and  analyzed for  t25I. (e)  Total binding  (+  PMA);  (o) total  binding  (-  PMA);  (A) 
nonspecific  binding (+  PMA); (zx) nonspecific  binding (-  PMA). 
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at 37°C. Adherent cells were recovered and analyzed for radioactivity. (e) PMA treated;  (o) control. 
105 cells/ml;  (B) concanavalin A substratum,  2  x  105 cells/ml. 
Figure 4. Adhesion to nonspecific 
substrata. Substrata were prepared 
by coating  tissue  culture  plates 
for 2 h at 37°C with various con- 
centrations  of the indicated pro- 
tein  in  PBS  and  then  blocking 
with albumin (see Materials and 
Methods). CHO cells were prela- 
beled with 35S, treated with 1 #M 
PMA for 10 min at 37°C, or main- 
tained as controls, and allowed to 
adhere to the substrata for 45 min 
(A) Polylysine substratum, 4.6  × 
3 B there are no differences in specific (GRGDSP-inhibita- 
ble) or nonspecific binding of '25I-fibronectin.  A number of 
binding studies were performed, all of which showed no sub- 
stantial  difference  in  binding  parameters.  The  estimated 
number of fibronectin  binding  sites  was  '~3  ×  10÷5/cell, 
while the Ks was "~-,10  -7 M; this is similar to previously re- 
ported results on fibronectin binding (2). These results indi- 
cate that PMA treatment does not directly affect the surface 
expression or binding characteristics of the FnR.  In other 
systems, phorbol ester treatment has been reported to "mod- 
ulate" surface  receptor expression  (32,  38);  this  does not 
seem to be the case for FnR, at least for the doses and times 
of exposure used here. Thus, the effects observed in Figs.  1 
C and 2, A and B,  cannot be ascribed to direct actions of 
PMA treatment on the binding characteristics of FnR itself. 
Rather, the effects produced by PMA, presumably mediated 
via protein kinase C, likely occur within the cell at the pos- 
treceptor level of the cell adhesion process. 
PMA Affects Integrin-mediated Adhesion but not 
Nonspecific Adhesion 
We wished to investigate whether the action of PMA demon- 
strated above was restricted to fibronectin-mediated adhesion 
or if adhesion processes to other substrata were also affected. 
In  addition,  we  wished  to  determine  if  PMA  treatment 
caused diverse effects on the cell membrane which might re- 
sult in nonspecific adhesion to virtually any type of substra- 
tum. To approach these questions, we examined adhesion of 
CHO cells on substrata coated with polylysine or Con A, 
where nonspecific cell attachment would likely occur (7). 
Adhesion of control or PMA-treated CHO cells to nonspe- 
cific polylysine- or Con  A-coated substrata were virtually 
identical (Fig. 4, A and B). A slight shift was noted for Con 
A, but one should keep in mind that the receptor for fibro- 
nectin is a glycoprotein and, along with other membrane gly- 
coproteins, may interact with Con A. Thus, PMA treatment 
does not markedly affect nonspecific adhesion processes. 
Cell adhesion receptors in CHO cells other than the FnR 
(7-9) have not been well explored. An interesting sidelight 
of our studies is that CHO cell adhesion to laminin and to 
vitronectin are also markedly enhanced by PMA treatment 
(data not shown). This seems similar to recent observations 
by Kato et al. (30), who demonstrated PMA enhancement of 
3T3 cell adhesion to laminin and to type IV collagen.  The 
nature of the receptors for laminin and vitronectin in CHO 
cells is undefned at this time, although it seems likely that 
integrins may be involved. 
Lack of  Phosphorylation of  FnR or Talin Subsequent 
to PMA Treatment 
We wished to investigate whether stimulation of protein ki- 
nase C  with PMA would result in altered patterns of phos- 
phorylation  in  CHO cells,  especially for FnR itself or for 
proteins likely to interact with FnR.  For example, talin,  a 
known substrate for protein kinase C in vitro (37),  is thought 
to interact with FnR (11, 25).  CHO cells were labeled with 
[32P]orthophosphate and, in some cases, treated with PMA 
for various intervals. The FnR and talin were immunoprecip- 
itated from the preparations and examined for PMA-induced 
phosphorylation  as  described  in  Materials  and  Methods. 
Phorbol ester-stimulated phosphorylations are known to of- 
ten display a  rapid rise followed by a decline (4,  38);  thus 
we examined a range of time points from 0.5 to 20 min. As 
seen in Fig. 5, with immunoprecipitation from whole cell ex- 
tracts, there is no apparent PMA-stimulated phosphorylation 
of either FnR or talin.  Indeed,  phosphorylation of FnR is 
barely  detectable  with  or  without  PMA  treatment;  talin 
phosphorylation is  more pronounced but does not change 
upon PMA treatment at any time point. Thus, there is little 
evidence that  the  phosphorylation  state  of the  whole  cell 
pools of talin or of FnR change upon PMA treatment, which 
is sufficient to promote cell adhesion. 
Since some integrins have been reported to be substrates 
for tyrosine kinases  in  other systems (23)  and  since other 
integrins  such  as platelet gplIb/IIIa may be substrates for 
protein kinase C (40a), we were concerned about our inabil- 
ity  (Fig.  5)  to detect  PMA-stimulated  phosphorylation of 
CHO cell FnR. It seemed important to pursue phosphoryla- 
tion experiments under conditions where chemically detect- 
able  amounts  of FnR  were  used  and  where  cell  proteins 
which were suitable substrates for kinases would be strongly 
labeled with 32pi. For this reason, we examined FnR phos- 
phorylation  under  conditions  which  would  promote  high 
specific activity of intracellular [32P]ATP pools and intense 
phosphorylation  of suitable  protein  kinase  substrates.  We 
also examined phosphorylation of FnR in a broken cell prep- 
aration. This condition should favor intense phosphorylation 
of susceptible proteins since ample exogenous [32pi]ATP is 
supplied and  since kinases should  have good access to all 
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phorylation of FnR or talin in whole cell ly- 
sates. CHO cells were preincubated  in al- 
pha  MEM  containing  5%  FCS  and  32pi 
(0.1 mCi/ml) at 106 cells/mi in 20 ml of to- 
tal volume for 3 h at 30°C. Cells then were 
exposed  to  1 tzM  PMA  or maintained  as 
control for different times at 37°C and lysed 
with  1 ml of a cold lysis buffer (see Mate- 
rials and Methods). FnR and talin were im- 
munoprecipitated  from lysates by incuba- 
tion of lysate with PB1-Affigel  at 4°C in the 
case of FnR, and subsequent incubation of 
lysate with antitalin antibody (see Materials 
and Methods) for 30 min at 4°C  and then 
with 60 t~l of protein A-Sepharose  4B per 
1 ml of lysate for 1 h at 4°C. Affigel and pro- 
tein A-Sepharose 4B were washed with ly- 
sis buffer and bound proteins were solubi- 
lized  by  SDS-containing  etectrophoresis 
sample buffer. Phosphoproteins in immuno- 
precipitates were separated by  10%  PAGE 
and visualized by autoradiography. (Lanes 
A-C)  Immunoprecipitates of FnR,  control 
samples with no PMA treatment;  0-,  10-, 
and 20-min  exposures.  (Lanes D-H)  Im- 
munoprecipitates of FnR,  PMA treated for 
0.5,  1,  5,  10,  and  20  min,  respectively. 
(Lanes AI-C~) Immunoprecipitates of talin, 
control  samples with  no PMA treatment; 
0-,  10-, 20-min  exposure.  (Lanes  D~-H~) 
Immunoprecipitates of talin,  PMA treated 
for 0.5,  1, 5,  10, and 20 min,  respectively. 
The positions of FnR and talin, from a par- 
allel immunoblot,  are indicated by arrows. 
proteins in the preparation. The results of these experiments 
are shown in Fig.  6, A and B,  respectively. 
The intact cell phosphorylation study (Fig.  6 A) clearly 
demonstrates that FnR is a very poor substrate for those ki- 
nases found in CHO cells. The silver stain shows a complex 
pattern of major and minor bands in the whole cell lysate 
(Fig. 6 A, lanes I  and 2) and a dense band representing FnR 
in the specific immunoprecipitate (Fig. 6 A, lanes 5 and 6). 
The immunoblot with anti-FnR antibody confirms the posi- 
tion of FnR (Fig. 6 A, lanes 13 and 14). The corresponding 
autoradiogram shows that several bands in the lysate which 
are present in relatively modest amounts chemically (Fig. 6 
A, lanes I  and 2) nonetheless are strongly labeled with 32pi 
(Fig. 6 A, lanes 7 and 8).  By contrast,  FnR which is quite 
abundant chemically (Fig. 6 A, lanes 5 and 6) is not detect- 
ably labeled with ~2Pi (Fig. 6 A, lanes//and 12).  Thus, the 
incorporation  of  32Pi into  FnR  on  a  molar basis  (moles 
Pi/mole protein) is much less than for several other cellular 
proteins; that is, FnR is a poor substrate not only for protein 
kinase C, but for all ki~nases present in intact CHO cells. No 
stimulation of phosphorylation of FnR was observed conse- 
quent to PMA treatment (Fig. 6 A, compare lanes//and 12). 
A similar result was found for the phosphorylation studies 
using broken cell preparations (Fig. 6  B).  The silver stain 
shows a complex pattern for the membrane-enriched, broken 
cell lysate (Fig. 6 B, lanes I  and 2) and a strong band corre- 
sponding to FnR in the specific immunoprecipitate (Fig.  6 
B, lanes 5 and 6). The identity of this band is confirmed in 
the immunoblot with anti-FnR antibody (Fig. 6 B, lanes 13 
and 14).  In the autoradiogram, strong incorporation of 32Pi 
is observed in some of the bands of the lysate (Fig. 6 B, lanes 
7 and 8). However, no phosphorylation of the abundant FnR 
band is seen (Fig. 6 B, lanes//and  12).  Thus, the in vitro 
phosphorylation  studies  confirm the  notion  that  FnR  is  a 
poor substrate for the array of kinases found in CHO cells. 
Discussion 
Phorbol ester treatment, presumably acting via stimulation 
of protein kinase C  (39), has been reported to have diverse 
and contrary effects on cell morphology and adhesion. Both 
cell rounding and cytoskeletal disruption (51), as well as en- 
hanced binding,  adhesion,  and cell spreading (5, 6, 28,  54) 
have been observed in different cell types. In this report we 
demonstrate  a  marked  enhancement  of integrin-mediated 
cell adhesion consequent to short exposure of CHO cells in 
suspension to phorbol ester (PMA). 
CHO cells treated  with  PMA  adhere  more rapidly and 
more efficiently to substrata coated with the extracellular ma- 
trix proteins fibronectin, laminin, and vitronectin. We have 
previously  shown  that  adhesion  to  fibronectin  involves a 
specific, integrin-type, membrane receptor (7). CHO adhe- 
sion to nonspecific substrata (polylysine or Con A  coated) 
is not noticeably affected by PMA treatment. The effects of 
The Journal of Cell Biology, Volume.108/I989  1930 Figure 6.  Lack of phosphorylation of FnR 
in vivo and in vitro. (A) Immunoprecipita- 
tion of  FnR from cells metabolically labeled 
with 32pi. (B) Immunoprecipitation of FnR 
from cell membrane fragments phosphor- 
ylated in vitro with gamma [32p]ATP. Lanes 
1-6, silver stain. Lanes I and 2, total lysate; 
lanes 3 and 4, precipitate with nonspecific 
Atfigel; lanes 5 and 6, immunoprecipitate 
with  PB1-Afligel. Lanes  7-12, autoradio- 
gram. Lanes 7 and 8, total lysate; lanes 9 
and 10, precipitate with nonspecific Affigel; 
lanes  //  and  12,  immunoprecipitate with 
PBI-Atiigei. Lanes 13 and 14, immunoblot 
with anti-FnR  polyclonal antibody of the 
PBI immunoprecipitate (Note: no immuno- 
reactive material was observed in immuno- 
blots of the nonspecific Aftigel precipitate; 
data not shown). 10% Laemmli gels were 
run under reducing conditions. Even lanes, 
samples treated with PMA; odd lanes, sam- 
ples without PMA treatment. 
PMA, thus, involve stimulation of receptor-mediated adhe- 
sion, but not global changes in membrane behavior leading 
to increased nonspecific adhesion. 
In  PMA-treated  cells,  the  efficiency of ligand-mediated 
adhesion is enhanced (i.e., the dose-response curve for li- 
gand is left shifted), while the potency of specific inhibitors 
of  adhesion is decreased (curve for inhibitor is right shifted). 
This could suggest an increase in the number or affinity of 
the specific ligand receptor subsequent to PMA treatment. 
In the case of FnR this possibility has been clearly ruled out. 
Measurement of the affinity of receptor sites (using  ~2sI-t~. 
bronectin), and of the number of  cell surface receptors (using 
antireceptor monoclonal ~2~I-PB1 antibody or '25I-fibronec- 
tin), show that PMA treatment has no effect on these param- 
eters. Thus,  the locus of PMA effects on integrin-mediated 
cell adhesion seems not to be on the abundance or binding 
characteristics of the receptor, but rather seems to be subse- 
quent to the initial ligand-receptor binding events. This is 
similar to the case of cAMP-dependent kinase regulation of 
cell adhesion (15, 16), which takes place at the postreceptor 
level, but differs from tyrosine kinase regulation of adhesion 
which may directly affect binding characteristics of the FnR 
(11, 23). 
It seems likely that integrins interact in some manner with 
cytoskeletal components during the formation of adhesive 
contacts (11-13). A possible mode of regulation of adhesion 
by protein kinase C  could involve phosphorylation of the 
integrin, or of a cytoskeletal protein, in a manner leading to 
enhanced binding affinity between these two types of mole- 
cules. Thus we wished to investigate FnR phosphorylation 
subsequent to PMA treatment. Since talin is known to inter- 
act with integrins and is thought to link membrane integrins 
to cytoskeletal components (12,  13, 25), we were interested 
in whether talin would become phosphorylated under condi- 
tions of PMA treatment that produced enhanced cell adhe- 
sion. However, we could not detect any enhanced phosphor- 
ylation of either talin or FnR due to PMA treatment of cells 
under treatment conditions which  would result in marked 
stimulation of adhesion to fibronectin. Indeed, the FnR seems 
to be a very poor substrate, not only for protein kinase C but 
also for other kinases available in CHO cells. The receptor 
fails to incorporate detectable amounts of 32pi under in vivo 
or in vitro labeling conditions which lead to substantial in- 
corporation of radiophosphate into other cell proteins. 
Thus, the treatment of CHO cells with PMA markedly en- 
hances integrin-mediated adhesion to fibronectin, without 
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agonist for protein kinase C,  one might expect that PMA 
treatment could lead to phosphorylation of the FnR or of pro- 
teins known to interact with the receptor.  This might result 
in changes in receptor expression at the cell surface, changes 
in the affinity  of the receptor for fibronectin, or changes in 
the interaction between fibronectin receptor and cytoskeletal 
proteins or membrane proteins. Our results clearly rule out 
some of these important possibilities. PMA treatment  does 
not result in altered expression or affinity  of the FnR.  Fur- 
ther, the receptor itself is quite a poor substrate for protein 
kinases. Thus, PMA modulation of adhesion, presuming it 
occurs through activation  of protein kinase C, must involve 
the phosphorylation of other cellular proteins which interact 
directly or indirectly with the receptor during the adhesion 
process, rather than via phosphorylation of the receptor it- 
self. Although talin might be a good candidate for such a pro- 
tein,  we were not able to detect PMA  stimulation of 32pi- 
incorporation into talin in CHO cells under conditions which 
lead to PMA-enhanced cell adhesion. 
In summary,  it seems probable that the marked enhance- 
ment  of cell  adhesion  to  fibronectin consequent  to  PMA 
treatment stems from altered phosphorylation of cytoskeletal 
proteins, yet to be identified, which are critically involved in 
postreceptor steps of this integrin-dependent adhesion pro- 
cess. Efforts are underway  to identify these critical compo- 
nents by examin/ttion  of protein kinase substrates  which are 
found in close association with FnR in cell-substratum adhe- 
sion sites. 
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